The tumor suppressor protein p53 negatively regulates cell growth (Finlay et al., 1989) . It is a common target for genetic alteration in human cancers and has been implicated as a key mediator of stress-induced growth arrest or apoptosis and for suppression of cell transformation (reviewed in Levine, 1993; Oren, 1994; Haner and Oren, 1995; Ko and Prives, 1996; Levine, 1997) . Growth suppression by p53 may be mediated through transcriptional control of speci®c target genes and/or by interaction with other cellular components. A molecular explanation for the pleitropic eects of p53 relies on its ability to act as a transcription factor. p53 can activate, through consensus p53 binding sites, a number of genes that have been implicated as functional targets in p53-induced growth repression or apoptosis. In addition to acting as a positive regulator of promoters with p53-binding sites, p53 often functions as a transcriptional repressor. The genes that are repressed by p53 usually do not contain a p53-binding site and include several genes whose activity is correlated with cell proliferation or malignant progression (for references, see Cairns and White, 1998) .
Since overexpression of p53 has been shown to both activate and repress transcription of dierent genes, this protein is likely part of a regulatory cascade that controls cell growth and neoplastic transformation. Notably, p53 has been shown to inhibit RNA polymerase III transcription in vivo (Chesnokov et al., 1996) , indicating that down-regulation of cellular biosynthetic capacities appears to be an ecient means to mediate growth suppression by p53. In the present study we have investigated whether p53 aects rDNA transcription. As actively growing cells require the ongoing synthesis of ribosomal RNA, one would expect that, if any, p53 exerts a negative eect on rDNA transcription.
To address this issue, we compared pre-rRNA synthesis in cell lines that express dierent levels of wild-type or mutant p53, respectively. First, we determined the level of pre-rRNA in MCO1 and MCO1/cG9-6 cells at 32 and 398C. MCO1 is a murine cell which is devoid of functional p53 (Halevy et al., 1991) , whereas MCO1/cG9-6 expresses a temperaturesensitive form of p53 (p53val135) which at elevated temperature (398C) changes its conformation and behaves, both biochemically and biologically, like mutant p53 (Michalovitz et al., 1990; Zauberman et al., 1993) . At the permissive temperature (328C) it assumes the features of wtp53 and, like authentic wtp53, can suppress oncogene-mediated transformation. The two cell lines were cultured for 24 h at the permissive and non-permissive temperature, respectively, and the relative amounts of pre-rRNA were determined on Northern blots using a probe speci®c for the 5'-end of the primary transcript. Since the primary transcript is rapidly processed 650 nucleotides downstream of the transcription start site (Kass et al., 1987) , this probe speci®cally detects newly synthesized, unprocessed 47S pre-rRNA molecules. As shown in Figure 1a , there was a clear dierence in the amount of pre-rRNA synthesized in MCO1/cG9-6 cells at 32 and 398C. At the non-permissive temperature the amount of pre-rRNA was 3.5-fold higher than at the permissive temperature ( Figure 1a , lanes 1 and 2). In the parental MCO1 cells, on the other hand, this dierence in pre-rRNA synthetic activity was much less pronounced, being only 1.4-fold higher at the non-permissive temperature (Figure 1a, lanes 3 and 4) . This result suggests that alterations of pre-rRNA levels in MCO1/cG9-6 cells in response to the temperature shift are due to an eect of p53 on rDNA transcription rather than to the temperature shift itself. Consistent with this, rRNA synthesis in MCO1/cG9-6 is lower at the permissive and higher at the non-permissive temperature compared to MCO1 cells (compare lanes 1 and 3 with 2 and 4), demonstrating a correlation between the presence of functional p53 and the level of cellular pre-rRNA synthesis.
To prove that p53 exerts an inhibitory eect on Pol I transcription under physiological conditions, we have compared the relative amount of pre-rRNA in primary embryonic ®broblasts from p53 knock-out mice (p53
) with control cells from wild-type mice (p53 +/+ ). The amount of pre-rRNA was found to be *fourfold higher in the p53-de®cient cells compared to control cells containing wtp53 (Figure 1b) . This dierence in the relative levels of pre-rRNA between p53-positive and p53-negative cells underscores the inhibitory eect of endogenous p53 on Pol I transcription.
As an alternative approach to reveal an inhibitory eect of p53 on pre-rRNA synthesis, we used the human cell line TR9-7 in which expression of p53 is repressed in the presence of tetracycline and is induced by tetracycline removal (Agarwal et al., 1995) . In the experiment shown in Figure 1c , the relative amount of pre-rRNA was measured in TR9-7 cells at dierent times after tetracycline removal. In parallel, induction of p53 expression was monitored on Western blots. Signi®cantly, cellular pre-rRNA synthesis was strongly inhibited after tetracycline withdrawal. The time course of the decrease of rDNA transcriptional activity coincided with that of p53 expression, supporting the view that there is a negative correlation between the level of cellular wtp53 and pre-rRNA synthetic activity.
In order to elucidate the mechanism by which p53 inhibits rDNA transcription, we investigated the eect of overexpression of wild-type or mutant p53 on rDNA transcription in transient transfection assays. The ribosomal reporter gene used (pMr5783-BH) represents a fusion of a 5'-terminal murine rDNA fragment (from 75783 to +292) with a 3'-terminal fragment containing two Pol I terminator elements ( Figure 2a ). De®ned 700 nt transcripts derived from this arti®cial ribosomal minigene were analysed on Northern blots using a riboprobe that hybridizes to pUC9 sequences located between the promoter and terminator sequences. Co-transfection of p53-defective (10)/1 cells (Harvey and Levine, 1991) with pMr5783-BH and increasing amounts of an expression vector encoding murine wtp53 strongly inhibited rDNA transcription ( Figure 2b , lanes 2 ± 4). Similarly, transcription of the murine Pol I reporter gene was repressed when an expression vector encoding human wtp53 was co-transfected (lane 9). Inhibition of Pol I transcription was observed with as little as 25 ng of pSGp53 (data not shown) and gradually increased with higher amounts of the expression vector. No repression was observed if vectors were used that express point mutants of p53 which do not bind DNA and have lost their growth suppressing function (Baker et al., 1989; Halevy et al., 1990; Kern et al., 1992; Halazonetis and Kandil, 1993) . All three point mutants tested, e.g. p53cys270 (lanes 5 ± 7), p53his175 (lane 10) or p53his273 (lane 11), did not aect transcription of the Pol I reporter plasmid. Thus, transcriptional repression depends on functionally active p53.
A p53-binding site extending from nucleotides 73517 to 73488 with respect to the transcription start site has previously been identi®ed in the spacer of the human ribosomal gene cluster, termed hRGC (Kern et al., 1991) . The functional relevance of this prospective p53-target site is not known. Inspection of the murine rDNA spacer did not reveal any obvious p53 target sequence. To investigate whether interaction of p53 with cryptic binding site(s) in the rDNA spacer may be required for p53-induced repression of rDNA transcription, we studied the eect of p53 on transcription of reporter plasmids which dier in the length of spacer sequences. pMr1930-BH and pMr170-BH are identical to pMr5783-BH, except that the sequences upstream of the transcription initiation site are shorter, extending to nucleotides 71930 and 7170, Figure 1 p53 decreases cellular pre-rRNA synthesis. (a) Increase of pre-RNA levels in a temperature-sensitive cell line. MCO1/ cG9-6, a murine cell line which expresses a temperature-sensitive form of p53 (Zauberman et al., 1993) , and the parental p53-de®cient cell line MCO1 (Halevy et al., 1991) were maintained for 24 h at the permissive (328C) or non-permissive temperature (398C), RNA was extracted, denatured and analysed on Northern blots using a riboprobe which hybridizes to the 5'-end (nucleotides 1 ± 155) of mouse pre-rRNA. To monitor RNA recovery, the blots were subsequently hybridized to a probe against cytochrome c oxidase (cox) mRNA. (b) Cells lacking p53 have elevated levels of pre-rRNA. The Northern blot shows the relative amount of pre-rRNA in p53 +/+ and p53 7/7 mouse embryo ®broblasts. (c) Repression of pre-rRNA synthesis by induction of p53. RNA was extracted from TR9-7 cells (Agarwal et al., 1995) at dierent times after removal of tetracyclin from the culture medium and analysed on Northern blots for expression of pre-rRNA (upper panel) and b-actin mRNA (middle panel). Expression of p53 was monitored by immunoblotting using an anti-p53 monoclonal antibody (Pab421, Dianova) p53+Pol I transcription A Budde and I Grummt respectively (Figure 2a ). In support of earlier studies showing transcriptional activation by the repetitive enhancer elements and upstream spacer sequences (Kuhn et al., 1990; Paalman et al., 1995) , the relative level of transcription from pMr170-BH was lower than that of pMr5783-BH and pMr1930-BH (Figure 2c , lanes 1, 3 and 5). Signi®cantly, overexpression of wtp53 reduced transcription of all three reporter plasmids to a similar degree (ca. ®vefold, lanes 2, 4 and 6), demonstrating that the minimal rDNA promoter is the target for p53-directed transcriptional repression. Thus, spacer sequences between nucleotides 75783 and 7170 increase the eciency of transcription, but do not play a role in repression by p53. The proposed pathway by which p53 suppresses cell growth involves transcriptional activation of the cdkinhibitor p21/WAF-1 which leads to cell cycle arrest in G1 (El-Deiry et al., 1993; Harper et al., 1993; Xiong et Figure 2 Overexpression of p53 represses transcription of a murine rDNA reporter plasmid. (a) Schematic representation of the rDNA reporter constructs used for transfections. The ribosomal minigene constructs contain a 5'-terminal mouse rDNA fragment fused to a 3'-terminal BamHI ± HinfI fragment containing two terminator elements, T 1 and T 2 . The black line represents pUC9 sequences. Speci®c transcripts (700 nt) terminated at the terminator element T 1 are indicated by a dashed arrow. (b) Co-transfection of expression vectors encoding wtp53 represses transcription of a Pol I reporter plasmid. p53-de®cient (10)/1 cells (Harvey and Levine, 1991) were co-transfected with 10 mg of pMr5783-BH and increasing amounts of the expression vectors encoding wild-type or mutant p53 as indicated. 10 mg of total RNA were fractionated on a formaldehyde 1.2% agarose gel, transferred to a Hybond-N membrane and analysed by Northern blot hybridization. Expression vectors encoding wild-type and mutant p53, pLTRp53cG, pLTRp53cGcys270, pCMV53, pCMV53-175 and pCMV53-273 were described (Baker et al., 1989; Halevy et al., 1990) . To detect transcripts from the rDNA reporter plasmids, a riboprobe was used encompassing pUC9 sequences from nucleotides 235 ± 396 (EcoRI ± NarI fragment). The blots were subsequently hybridized to a riboprobe against b-actin mRNA. (c) Intergenic rDNA spacer sequences do not contribute to p53-directed repression of Pol I transcription. (10)/1 cells were transiently transfected with 1 mg pSGp53 (Staib et al., 1996) and equimolar amounts of Pol I reporter plasmids which dier in the length of upstream spacer sequences (pMr5783-BH, pMr1930-BH and pMr170-BH). Transcripts were analysed on Northern blots as above. (d) Overexpression of p21 does not aect transcription of a murine rDNA reporter plasmid. p53-de®cient (10)/1 cells were cotransfected with 10 mg of pMr5783-BH and 2 mg of expression vectors encoding wtp53 or p21 as indicated. 10 mg of total RNA were analysed on Northern blots p53+Pol I transcription A Budde and I Grummt al., 1993; Dulic et al., 1994) . To exclude the possibility that repression of Pol I transcription is a consequence of p21-mediated growth suppression, the eect of overexpressing p53 and p21 on Pol I transcription was compared. In the experiment shown in Figure 2d , expression plasmids encoding p53 and p21, respectively, were cotransfected with the rDNA reporter pMr5783-BH, and Pol I speci®c transcripts were monitored on Northern blots. Again, overexpression of p53 reduced transcripts from the rDNA reporter more than ®vefold (Figure 2d, lane 2) . In contrast, overexpression of p21 did not in¯uence expression of the rDNA reporter (lane 3). This result demonstrates that repression of rDNA transcription observed after transfection of (10)1 cells with expression plasmid encoding p53 is not mediated by p21.
To determine whether the eect of p53 upon Pol I transcription is direct, i.e. whether p53 interferes with the basal Pol I transcriptional apparatus, we tested the eect of wild-type and mutant p53 on rDNA transcription in vitro. The cell-free system used contains nuclear extract from HeLa cells, a template encompassing human rDNA sequences from 7411 to +379 (P¯eiderer et al., 1990) , and p53 puri®ed from baculovirus-infected Sf9 cells. The purity and quantity of dierent preparations of p53 were compared on SDS-polyacrylamide gels and the DNA binding activity of p53 was determined by electrophoretic mobility shift assays. To control for p53 function in transcription, a template containing the polyomavirus promoter fused to several p53 binding sites was used (PG 13 CAT, Kern et al., 1992) . When linked to a Pol II promoter, the p53 binding site confers p53-dependent transcriptional activation of the respective target gene (Funk et al., 1992; Farmer et al., 1992) . Consistent with p53 activating Pol II-directed transcription, wtp53 stimulated transcription of PG 13 CAT in a dose-dependent manner ( Figure 3a , lanes 2 ± 5). Mutant p53 (p53his175), on the other hand, had no eect ( Figure  3a, lanes 6 and 7) . Remarkably, the same preparations of p53 did not aect transcription of the Pol I template (Figure 3b ). Even at high amounts of p53 (1 mg) no reduction of Pol I transcription was observed. Several preparations of recombinant p53 puri®ed from either E. coli or Sf9 cells as fusion protein with dierent Nterminal tags (GST, 6xhistidines, FLAG) yielded the same result (data not shown). Some preparations of wtp53 inhibited Pol I transcription in vitro, however, in these cases transcriptional repression was not caused by p53 but rather by contaminating proteins, because mutant p53his175 which was expressed and puri®ed in parallel exhibited the same repressive eect.
The incapability of p53 to inhibit Pol I transcription in vitro was unexpected, because two recent reports have demonstrated repression of Pol III transcription by GST-p53 in HeLa cell extracts (Chesnokov et al., 1996; Cairns and White, 1998) . In several respects, basal mechanisms of transcriptional regulation are similar for class I and III genes. For example, we and others have shown that the retinoblastoma tumorsuppressor protein (pRb) can repress Pol I transcription in vitro (Cavanaugh et al., 1995; Voit et al., 1997) , a ®nding that implicates down-regulation of rDNA transcription as a mechanism for pRb-induced growth arrest. Like p53, pRb restricts cellular proliferation and is often found mutated in transformed cells (Weinberg, 1995) . pRb exerts a negative eect on transcription by both Pol I and Pol III. This ®nding may explain why loss of tumor suppressor function enables tumor cells to increase their overall biosynthetic capacity and supports a growing number of studies which establish a link or overlap of p53 and pRb function. Recombinant human wild-type (wtp53) and mutant p53 (p53his175) were expressed as N-terminally FLAG-tagged proteins in baculovirus-infected Sf9 cells and puri®ed as described (Voit et al., 1997) . Increasing amounts of p53 (as indicated above the lanes) were preincubated for 30 min at 308C with HeLa nuclear extract (Dignam et al., 1983) , before the template and ribonucleotides were added, and the reactions were incubated for 1 h at 308C. (a) p53 activates Pol II transcription. Transcription reactions contained 1 mg of PG 13 -CAT (Kern et al., 1992) linearized with BamHI, 50 mg of HeLa nuclear extract proteins, 50 mM Tris-HCl (pH 7.9), 6 mM MgCl 2 , 0.1 mM EDTA, 0.5 mM DTT, 50 mM KCl, 8% glycerol and 0.66 mM of each ATP, CTP, GTP and UTP. Transcripts were analysed by primer extension using a labeled oligonucleotide (5'-CACTGGATATAC-CACCGTTG-3') which is complementary to 5'-terminal sequences of the CAT gene (Grummt and Skinner, 1985) . (b) p53 does not repress Pol I transcription. Transcription reactions containing 50 ng of the human rDNA template pHrP 2 /EcoRI were performed as described (P¯eiderer et al., 1990) . Run-o transcripts were analysed by electrophoresis on 4.5% polyacrylamide gels and visualized by autoradiography At present we are ignorant why ± in contrast to pRb ± p53 does not aect Pol I transcription in vitro. Notably, in our hands and dierent experimental conditions, recombinant p53 stimulated Pol II transcription, but had no eect on Pol I or Pol III transcription. We have performed a series of experiments to reproduce repression of Pol III transcription in vitro, but failed to observe any p53-speci®c inhibition of 5S, VA I and U6 RNA transcription (data not shown). Since neither study showing p53-mediated repression of Pol III (Chesnokov et al., 1996; Cairns and White, 1998) used mutant p53 to exclude nonspeci®c inhibition by bacterial contaminating proteins, it is hard to reconcile our apparent contradictory results. It is conceivable that a speci®c posttranslational modi®cation is required for repression of class I and III genes in vivo, and this modi®cation is not present in the recombinant p53 preparations used for the in vitro studies. Furthermore, p53 could require a natural template, i.e. chromatin rather than naked DNA, to interact with the basal Pol I transcription apparatus. Consistent with both possibilities, the recent ®nding that p53 is acetylated by p300/CPB (Gu and Roeder, 1997) suggests that p53-p300 interactions facilitate both increased DNA binding and subsequent interactions with the initiation complex (e.g. TBP and TAFs). Alternatively, inhibition of cellular Pol I transcription may not be due to a direct eect of p53 on the basal transcription machinery, but rather is a consequence of p53 aecting positively or negatively the synthesis of genes which code for factors required for rRNA synthesis. In this scenario, repression of Pol I transcription would be brought about by either a negative-acting factor which is induced by p53 or by an activating protein which is down-regulated in the presence of p53. Whatever the mechanism of p53-mediated inhibition of Pol I transcription may be, the observation that p53 controls the production of rRNA and thus ribosome synthesis, is consistent with the antiproliferation eects of this tumor suppressor. It is well established that induction or overexpression of p53 leads to cell cycle arrest or apoptosis (Lin et al., 1992; Oren, 1994; Shaw et al., 1992) . Pol I transcription, on the other hand, is tightly coordinated with cell growth, i.e. rRNA synthesis is down-regulated when cells approach stationary phase, are starved of an essential nutrient, or are exposed to protein synthesis inhibitors (reviewed by Paule, 1994; Moss and Stefanovsky, 1995; Grummt, 1998) . Future studies will address questions concerning the mechanism of Pol I transcription inhibition by p53 to ®nally understand whether and how rDNA transcriptional regulation by p53 is a means of restraining cell proliferation.
